The study hasn't yet been reviewed by other scientists and formally published, but Prof Stephen Evans at the London School of Hygiene and Tropical Medicine, described it as "high quality" and "very encouraging".
He said: "Last month I announced a new vaccine task force to co-ordinate the efforts of Government, academia and industry in the critical mission to find a vaccine".
A closely watched coronavirus vaccine being developed by scientists at Oxford University appears protective in a small study of six monkeys, promising findings that led to the start of human trials late last month, US and British researchers reported on Thursday.
Professor Dr. Penny Ward of King's College London said, "These results support the ongoing testing of the vaccine on humans".
On Saturday, Chinese health official, Zhang Wenhong said a successful vaccine against the coronavirus can be administered to humans as early as March in 2021.
According to the study, a single dose of vaccine can also protect against damage to the lungs and organs that the corona virus can severely affect. Researchers found that some of the monkeys developed antibodies in 14 days after applying the vaccine and some of them in 28 days. "We'll have a vaccine much sooner rather than later". "So large scale is feasible, we believe".
In a further announcement, Sharma said a global licensing agreement had been finalised between Oxford University and AstraZeneca. The first tranche of volunteers have received the Oxford vaccine, with Imperial due to start clinical trials by mid-June.
Hill has stated that as much as one million doses of the shot are already being manufactured and can be accessible by September, even earlier than trials totally show whether or not it really works.
"This means that if the vaccine is successful, AstraZeneca will work to make 30 million doses available by September for the United Kingdom as part of the agreement to deliver 100 million doses in total", he added.
Mr Sharma said the Government has now committed more than a quarter of a billion pounds towards developing a vaccine in the UK.
The article is the latest to reflect a change in tone of the prime minister's optimism.
"I think we'll have a vaccine by the end of the year", Trump said at a Fox News virtual town hall. The vaccine has to be used to prevent the corona virus from being infected in a wider population.
Researchers concerned with the ChAdOx1 nCoV-19 trials stated the vaccine had proven indicators of priming the rhesus macaque monkeys' immune methods to fend off the lethal virus and confirmed no indications of opposed results.